Understanding how different pain medicines work for knee arthritis
Brain-based and clinical phenotyping of pain pharmacotherapy in knee OA
This project aims to discover specific signs in individuals with knee arthritis pain that help predict which pain medication will work best for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11145653 on NIH RePORTER |
What this research studies
If you have moderate to severe knee arthritis pain, this project is looking for ways to personalize your pain treatment. Participants will receive either naproxen, duloxetine, or a placebo to see how each affects their pain. Researchers will collect various health information, including surveys, physical tests, blood samples, and brain and joint imaging, both before and after treatment. This helps us understand why certain treatments work better for some people than others. The goal is to find unique patterns that guide doctors to the most effective pain relief for each individual.
Who could benefit from this research
Good fit: Ideal candidates are individuals experiencing moderate to severe pain from knee osteoarthritis.
Not a fit: Patients without knee osteoarthritis pain or those not seeking new pain management strategies would not directly benefit from participating in this specific project.
Why it matters
Potential benefit: If successful, this work could lead to more personalized and effective pain management strategies for people with knee arthritis, reducing trial-and-error in finding the right medication.
How similar studies have performed: While the medications used are established, this project's approach of identifying individual biomarkers to predict specific treatment responses is a novel strategy for personalizing pain care.
Where this research is happening
Chicago, United States
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Schnitzer, Thomas Jack — Northwestern University
- Study coordinator: Schnitzer, Thomas Jack
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.